[1]
D. Dharman, K. G. Revikumar, and L. Thomas, “Pharmacoeconomic analysis of type 2 diabetes mellitus and its microvascular complications”, Int J Res Pharm Hos & Clin. Pharm, vol. 1, no. 1, pp. 11-14, Sep. 2018.